(R)-Thalidomide

  Cat. No.:  DC28973   Featured
Chemical Structure
2614-06-4
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
The R-enantiomer of thalidomide, (R)-(+)-thalidomide, exhibits sedative effects distinct from its racemic counterpart.
Cas No.: 2614-06-4
Chemical Name: (R)-(+)-Thalidomide
Synonyms: 1H-Isoindole-1,3(2H)-dione,2-[(3R)-2,6-dioxo-3-piperidinyl]-;(R)-(+)-Thalidomide;(+)-Thalidomide;(R)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione;R-(+)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;BIDD:ER0498;(+)-(R)-THALIDOMIDE;NSC 91729;R-(D)-THALIDOMIDE;2-[(3~{R})-2,6-bis(oxidanylidene)piperidin-3-yl]isoindole-1,3-dione;J-016277;EN300-7507077;N-(I+/--Glutarimidyl)phthalimide;CCG-36381;6EL;rac-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;N-(alpha-Glutarimido)-phthalimide;Q27131492;D-Thalidomide;Thalidomide, (R)-;QN61H68KLK;CS-0021929;2614-06-4;AKOS040736366;BDBM65362;(+)-Thalidomide, >=98% (HPLC), powder;CHEBI:61917;(R)-(D)-Thalidomide;2-[(3R)-2,6-dioxopiperidin-3-yl]-1H-isoindole-1,3(2H)-dione;2-((3R)-2,6-DIOXO-3-PIPERIDINYL)-1H-ISOINDOLE-1,3(2H)-DIONE;R-(+)-Thalidomide;UNII-QN61H68KLK;2-[(3R)-2, 6-dioxopiperidin-3-yl]isoindole-1, 3-dione;DTXSID6046971;1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (R)-;Phthalimide, N-(2,6-dioxo-3-piperidyl)-, D-(+)-;NS00125616;Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (+)-;SCHEMBL41641;2-[(3R)-2,6-dioxopiperidin-3-yl]isoindole-1,3-dione;1H-ISOINDOLE-1,3(2H)-DIONE, 2-((3R)-2,6-DIOXO-3-PIPERIDINYL)-;(R)-Thalidomide;2-[(3R)-2,6-dioxopiperidin-3-yl]-2,3-dihydro-1H-isoindole-1,3-dione;NSC-91729;CHEMBL558551;HY-14658B;AT44366;(R)-(+)-2-(2,6-Dioxo-3-piperidinyl)-1H-iso-indole-1,3(2H)-dione; (R)-Thalidomide; NSC 91729;;2-((3R)-2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione;DTXCID4026971;DA-48762
SMILES: O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
Formula: C13H10N2O4
M.Wt: 258.2295
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
TITLE DOWNLOAD
MSDS_13024_DC28973
COA
LOT NO. DOWNLOAD
Cat. No. Product name Field of application
DC67413 MRT-23227
DC67412 MRT-3486
DC67411 MRT-7612
DC67410 MRT-10350
DC67407 IKZF1-degrader-1 IKZF1-degrader-1 (Compound 9-B) is a highly potent molecular glue that achieves sub-nanomolar degradation of IKZF1 (DC50 = 0.134 nM), demonstrating significant therapeutic potential for targeting IKZF1-dependent malignancies.
DC67406 EM12-FS EM12-FS is a bifunctional CRBN modulator that engages cereblon at His353 while functioning as a molecular glue to induce NTAQ1 degradation. Demonstrating favorable pharmacokinetics, it exhibits a human plasma half-life of 196 minutes, supporting its therapeutic potential.
DC67405 Acetyl-cyclosporin A aldehyde Acetyl-cyclosporin A aldehyde is a chemically modified derivative of cyclosporin A (HY-B0579), featuring an acetyl group and a reactive aldehyde moiety. The parent compound, cyclosporin A, is a dual-function molecule that both inhibits calmodulin signaling and binds cyclophilin, thereby blocking NF-AT nuclear translocation and inducing mitochondrial dysfunction.
DC67404 QS-57 QS-57 is a bifunctional degrader that combines BRD4-targeting PROTAC activity with 14-3-3 molecular glue properties.
DC67403 KRAS ligand 4 KRAS ligand 4 (compound 2) is a SOS1-targeting bifunctional molecular glue that suppresses oncogenic signaling by degrading key KRAS pathway components, evidenced by reduced pERK and pS6 levels. It demonstrates broad-spectrum activity against diverse KRAS mutations, disrupting proliferation across resistant cancer models.
DC67402 Pomalidomide-15N,13C5 Pomalidomide-15N,13C5 is a stable isotope-labeled variant of pomalidomide (HY-10984), a third-generation immunomodulatory drug that functions as a cereblon-directed molecular glue. This compound mediates targeted ubiquitination and degradation of Ikaros family transcription factors (IKZF1/3) through recruitment of the CRL4CRBN E3 ligase complex, underpinning its therapeutic mechanism.
X